Investing Profile

Michael Ehlers

InvestorVC
Chief Scientific Officer & Venture Partner at ATP
appletreepartners.com/teamCambridge, Massachusetts
Photo of Michael Ehlers, Venture Partner at ATP (Apple Tree Partners)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
10
CompanyStageDateRound SizeTotal Raised
Deep Apple Therapeutics
Series ADec 2023$52M
$52M
Co-investors: Paul Da Silva Jardine (ATP (Apple Tree Partners)), Paul Eisenberg (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Ascidian Therapeutics
Series ANov 2023$40M
Series AOct 2022$50M
$90M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners))
Aulos Bioscience
Series AAug 2023$20M
Series AJan 2021$40M
$60M
Co-investors: Joseph A. Yanchik III (ATP (Apple Tree Partners))
Initial Therapeutics
Series AMay 2023$75M
$75M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Intergalactic Therapeutics
Series AOct 2021$75M
$75M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners))
Replicate Bioscience
Series ASep 2021$40M
$40M
Co-investors: Joseph A. Yanchik III (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners))
Nereid Therapeutics
Series ANov 2020$50M
$50M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Nine Square Therapeutics
Series AJul 2020$50M
$50M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners))